F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
Based on observation, interview and record review, the facility failed to ensure expired oral medications and
topical creams were removed from the current medication supplies. In addition, nasal sprays, eye drops,
and pain patches were commingled with the current medication supplies readily available for residents' use.
Also, the medication room temperature was not consistently monitored as required.
These failures had the potential for unsafe storage of medications thereby losing the efficacy of the
medications.
Findings:
1a. On 9/4/19 at 9:32 A.M., a medication storage inspection of the treatment cart and interview was
conducted with Licensed Nurse (LN) 1. The treatment cart had five drawers. In the first drawer, there was
half a box of individual packets of hydrocortisone cream (topical medication used to help relieve redness,
itching, swelling) with an expiration date of 8/19.
In the fifth drawer, there was one opened tube of benzoyl peroxide 10 % (medication used to treat mild to
moderate acne) with an expiration date of 9/18, and one tube ointment of a soothe and cool barrier
(moisture ointment) with an expiration date of 8/19. LN 1 stated the LNs should have been checking at the
expiration date of the medications and discarded the expired treatment medications. LN 1 acknowledged
the policy and guidelines on storage of medications should have been followed.
On 9/5/19 at 2:10 P.M., an interview was conducted with the Director of Nursing (DON). The DON LNs
should have checked the treatment and medication carts to ensure medications were current.
A review of the facility's policy titled, Storage and Expiration of Medications, Biologicals, Syringes and
Needles, revised 10/31/16, indicated, Procedure . 3. General Storage Procedures: . 3.2 Facility should
ensure that external use medications and biologicals are stored separately from internal use medications
and biologicals . 5. Once any medication or biological package is opened, Facility should follow the
manufacturer/ supplier guidelines with respect to expiration dates for opened medications . 5.2 Medications
with a manufacturer's expiration date expressed in month and year (e.g. May 2019) will expire on the last
day of the month .
2. On 9/4/19 at 10:17 A.M., a medication storage inspection, interview, and record review was conducted
with LN 1. There were 15 missing signatures in the medication room temperature log in PM shifts. The
dates were identified as follows: 1/3, 1/5, 1/7, 1/8, 1/9, 1/15, 1/16, 1/17, 1/21, 1/27, 1/29,
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
055500
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055500
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/06/2019
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Post Acute
1025 W. Second Avenue
Escondido, CA 92025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
4/11, 4/12, 4/14, and 4/15/19.
Level of Harm - Minimal harm
or potential for actual harm
LN 1 stated the medication room temperature should have been checked and monitored by the LNs twice a
day for a potential that temperature would be out of range. LN 1 also stated LNs should have monitored the
temperature consistently to maintain the effectiveness and potency of the medications.
Residents Affected - Some
On 9/5/19 at 2:10 P.M., an interview was conducted with the Director of Nursing (DON). The DON further
stated the medication room temperatures should have been monitored twice a day consistently to ensure
the potency of the medications. The DON stated who knows the temperature was off and could affect the
medications' effectiveness.
A review of the facility's policy titled, Storage and Expiration of Medications, Biologicals, Syringes and
Needles, revised 10/31/16, indicated, Procedure . 3. General Storage Procedures: .11. Facility should
ensure that medications and biologicals are stored at their appropriate temperatures according to the
United States Pharmacopoeia guidelines for temperature ranges.
3a. On 9/4/19 at 12:03 P.M., a medication storage inspection of North medication cart and interview was
conducted with LN 2. A half bottle of opened oral vitamin tablets was inside the drawer with an expiration
date of 8/19. LN 2 stated the expired medications should have been removed from the cart.
On 9/5/19 at 2:10 P.M., an interview was conducted with the Director of Nursing (DON). The DON stated
the treatment cart and the medication cart should have been checked to ensure medications were
organized and current. The DON stated it was missed and could potentially hurt the residents.
A review of the facility's policy titled, Storage and Expiration of Medications, Biologicals, Syringes and
Needles, revised 10/31/16, indicated, Procedure . 3. General Storage Procedures: .5. Once any medication
or biological package is opened, Facility should follow the manufacturer/ supplier guidelines with respect to
expiration dates for opened medications .5.2 Medications with a manufacturer's expiration date expressed
in month and year (e.g. May 2019) will expire on the last day of the month .
3b. On 9/4/19 at 12:03 P.M., a medication storage inspection of the medication cart and interview was
conducted with Licensed Nurse (LN) 1. Multiple medication supplies were commingled inside the drawer
such as: Nasal sprays, eye drops, pain patches, and anticoagulant liquid medications. LN 2 stated she was
not sure of the facility's policy related to the storage of nasal sprays, eyes drops, pain patches, and oral
medications. LN 2 stated oral medications should have been separated from nasal sprays, eye drops, and
patches for safety reasons.
On 9/5/19 at 2:10 P.M., an interview was conducted with the Director of Nursing (DON). The DON stated
LNs should have checked the treatment and medication carts to ensure the medications were organized
and current. The DON stated it was missed and could potentially hurt the residents and storage of internal
and external medications should have been separated. The DON also stated oral medications should have
been separated from the other medications to prevent medication error and for infection control purposes.
A review of the facility's policy titled, Storage and Expiration of Medications, Biologicals, Syringes and
Needles, revised 10/31/16, indicated, Procedure . 3. General Storage Procedures: . 3.2 Facility should
ensure that external use medications and biologicals are stored separately from internal
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055500
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055500
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/06/2019
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Post Acute
1025 W. Second Avenue
Escondido, CA 92025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
use medications and biologicals .5.2 Medications with a manufacturer's expiration date expressed in month
and year (e.g. May 2019) will expire on the last day of the month .
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055500
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055500
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/06/2019
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Post Acute
1025 W. Second Avenue
Escondido, CA 92025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0912
Level of Harm - Potential for
minimal harm
Residents Affected - Some
Provide rooms that are at least 80 square feet per resident in multiple rooms and 100 square feet for single
resident rooms.
Based on observation, interview, and review of the Analysis of Client Accommodations, the facility failed to
meet the required minimum square footage requirements of at least 80 square feet per resident (sq
ft/resident) in 3 resident bedrooms (6, 8, and 11). This failure had the potential to impact resident care and
quality of life.
Findings:
An observation from 9/3/19 through 9/5/19 was conducted during the survey. The following resident rooms
contained less than 80 square feet for each resident:
Room number
Room Size
6 accommodated 3 residents 216 (72 sq ft/resident)
8 accommodated 3 residents 216 (72 sq ft/resident)
11 accommodated 2 residents 138 (69 sq ft/resident)
Additionally, interviews and records reviews were conducted. There were no observed quality of care, or
quality of life concerns that negatively affected the residents residing in the identified rooms during the
recertification survey visit.
A continuance of the waiver (variation) from the requirements of Code 42 of the Federal Regulations (CFR)
section 483.70(d)(1)(ii) as granted, allowing less than 80 square feet per resident room, is hereby
recommended. This recommendation is also made with the expectation that the facility will obtain a timely
renewal of the current waiver granted by CMS.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055500
If continuation sheet
Page 4 of 4